Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Exicure Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
XCUR
Nasdaq
8731
https://www.exicuretx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Exicure Inc
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-K
- Apr 22nd, 2024 8:01 pm
Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis
- Feb 5th, 2024 9:01 pm
Lacklustre Performance Is Driving Exicure, Inc.'s (NASDAQ:XCUR) 25% Price Drop
- Aug 29th, 2023 10:02 am
Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors
- Aug 23rd, 2023 1:48 pm
Exicure First Half 2023 Earnings: US$1.38 loss per share (vs US$3.71 loss in 1H 2022)
- Aug 15th, 2023 10:04 am
Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update
- Aug 11th, 2023 8:01 pm
Exicure, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update
- Jul 14th, 2023 8:01 pm
Exicure, Inc. Announces Support of CEO in its Ongoing Exploration of Strategic Alternatives
- May 26th, 2023 8:01 pm
Scroll